Shrinking Lung Syndrome — RACP Adult Medicine MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — Pulmonary hypertension
Shrinking lung syndrome (SLS) is an uncommon but recognised pulmonary complication of SLE characterised by progressive dyspnoea, small lung volumes (elevated hemidiaphragms on CXR), and restrictive PFTs WITHOUT significant parenchymal disease. The preserved DLCO corrected for alveolar volume distinguishes it from ILD. The pathogenesis is uncertain – diaphragmatic dysfunction from phrenic nerve or diaphragmatic myopathy is hypothesised. Treatment includes corticosteroids, rituximab, or other immunosuppression. Response is variable.
Reference: eTG – 2025 – Rheumatology; Toya & Tzelepis – 2009 – Shrinking Lung Syndrome Review